Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Rex Eupseiphos's Profile
Displaying 1-50 of 156 result(s).
CYDY CytoDyn Inc
09/04/2020 8:57:49 AM
yes, but politics speak very loudly
CYDY CytoDyn Inc
08/15/2020 11:52:02 AM
severe trial update...not likely be (4)
CYDY CytoDyn Inc
08/07/2020 12:54:59 AM
good result but not statistically s
CYDY CytoDyn Inc
08/01/2020 9:03:35 PM
Enrollment is getting close to 200,
CYDY CytoDyn Inc
07/29/2020 11:49:44 AM
"markets don't seem to care about l (2)
CYDY CytoDyn Inc
07/23/2020 12:37:33 AM
Uh, OK. Let L0, L1, P0, P1 be the n
CYDY CytoDyn Inc
07/22/2020 11:45:26 PM
because the s/c trial is 2:1, there (3)
CYDY CytoDyn Inc
07/22/2020 6:34:17 PM
sorry, CDiddy. I meant to be replyi (1)
CYDY CytoDyn Inc
07/22/2020 6:17:32 PM
m/m trial metrics (5)
CYDY CytoDyn Inc
07/22/2020 10:17:24 AM
Agreed. the SAE/AE data give strong (1)
CYDY CytoDyn Inc
07/21/2020 11:59:44 AM
Nonsensical update to PR: "39% (11 (4)
CYDY CytoDyn Inc
07/21/2020 9:24:30 AM
Because the subhead is apparently w
CYDY CytoDyn Inc
07/21/2020 9:21:07 AM
Let the seller beware! The SP will (5)
CYDY CytoDyn Inc
07/21/2020 8:28:22 AM
Take the S out of the SAE in the su (2)
CYDY CytoDyn Inc
07/21/2020 8:14:20 AM
or "Leronlimab reduces patients wit
CYDY CytoDyn Inc
07/20/2020 10:30:40 PM
disagree. he was talking about medi (7)
CYDY CytoDyn Inc
07/17/2020 5:29:07 PM
No one knows, but exciting biotech
CYDY CytoDyn Inc
07/17/2020 4:43:49 PM
What P/E ratio do you assmue?
CYDY CytoDyn Inc
07/17/2020 4:04:57 PM
He's welcome to play at my table in (1)
CYDY CytoDyn Inc
07/17/2020 3:31:51 PM
and an excited NP on Dr Been tomorr (1)
CYDY CytoDyn Inc
07/17/2020 11:15:58 AM
yep...safe for a nicely coordinated (1)
CYDY CytoDyn Inc
07/15/2020 9:05:35 PM
I'm betting the m/m results are goi (2)
CYDY CytoDyn Inc
07/15/2020 1:19:27 PM
a joke...think about it (1)
CYDY CytoDyn Inc
07/15/2020 12:29:29 PM
Occam's razor...what's that? "It's (1)
CYDY CytoDyn Inc
07/14/2020 10:57:11 AM
thanks, kabonk. I'd forgotten about (3)
CYDY CytoDyn Inc
07/13/2020 8:38:01 PM
excellent explanation, havasu78. th
CYDY CytoDyn Inc
07/13/2020 10:20:41 AM
it's important to get the statistic
CYDY CytoDyn Inc
07/12/2020 12:21:17 PM
Have you seen any measures of viral (1)
CYDY CytoDyn Inc
07/12/2020 12:07:27 PM
Is there a distinction between plas
CYDY CytoDyn Inc
07/12/2020 11:23:51 AM
Thanks, CTMedic! I appreciate the e (3)
CYDY CytoDyn Inc
07/12/2020 11:07:31 AM
Plasma viral load has been detected (2)
CYDY CytoDyn Inc
07/12/2020 10:47:50 AM
Good morning, TechGuru. I hate to g (18)
CYDY CytoDyn Inc
07/11/2020 11:48:36 PM
p-values were large because the sta
CYDY CytoDyn Inc
07/11/2020 9:27:58 PM
this is more credible than the Pers
CYDY CytoDyn Inc
07/11/2020 9:05:23 PM
and he withdrew the post
CYDY CytoDyn Inc
07/10/2020 1:31:05 PM
4, 1, 2, 3...papers are not likely
CYDY CytoDyn Inc
07/10/2020 12:13:15 PM
"submitted" and "going to be publis (1)
CYDY CytoDyn Inc
07/10/2020 12:11:06 PM
There is no "peer review" at medrXi
CYDY CytoDyn Inc
07/09/2020 3:33:31 PM
NP gave a nice presentation of HIV (7)
CYDY CytoDyn Inc
07/09/2020 3:10:30 PM
Dr. Patterson is a scientist, not a (1)
CYDY CytoDyn Inc
07/09/2020 2:17:18 PM
Wow. I hope this is the last time t (6)
CYDY CytoDyn Inc
07/05/2020 9:11:20 PM
yep. The blood work for the trials
CYDY CytoDyn Inc
07/05/2020 7:15:17 PM
havasu78: I am assuming that Patter
CYDY CytoDyn Inc
07/04/2020 1:54:18 PM
profit-taking? Fne. Market manipula
CYDY CytoDyn Inc
07/04/2020 1:55:08 AM
the statistical calculations should
CYDY CytoDyn Inc
07/03/2020 5:14:30 PM
Does HIPAA allow a researcher to do
CYDY CytoDyn Inc
07/03/2020 2:47:51 PM
a few questions, blafarm... The blo (4)
CYDY CytoDyn Inc
07/01/2020 6:29:12 PM
this morning NP said s/c was at 120
CYDY CytoDyn Inc
07/01/2020 6:03:01 PM
the s/c trials involve very little
CYDY CytoDyn Inc
06/26/2020 11:24:48 PM
In the 6/11 CC, MM said they were a (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch benzingaheadline@gmail.com. Target readers who trust our platform to stay ahead of the curve.

Recent Articles

  • Biohaven Ltd Investors Invited to Join Class Action Efforts
  • Leading Class Action Against Savara Inc. Explained for Investors
  • Travelers Companies: A 5-Year Investment Journey Unveiled
  • Global Uranium Corp. Launches Private Placement Offering
  • Significant Legal Developments for Fly-E Group Investors
  • Exploring the Financial Growth of AeroVironment Over 15 Years
  • Capricor Therapeutics: Investors Thankful for Class Action Alert
  • Global Uranium Corp. Secures C$1.5M Offering for Growth
  • Flagship REIT Enhances Financial Strength with New Credit Facility
  • KinderCare Investors May Join Lawsuit for Securities Misconduct
  • Lam Research Launches Revolutionary VECTOR TEOS 3D Tool
  • Trailblazer Acquisition Corp. Completes $240 Million IPO Launch
  • iManage Cloud Expansion Grows in Asia Amidst Legal Innovation
  • Transform Your Investment: The 20-Year Journey of BlackRock
  • Waymo's Bold Step: Testing Autonomous Vehicles in NYC
  • A Deep Dive into L3Harris Technologies Stock Performance
  • Apple's iPhone 17 Launch Sparks Anticipation for New Era
  • Join the Luminar Technologies Class Action and Protect Your Rights
  • Investors Can Engage in Semler Scientific Securities Action
  • Innovative Training Initiative for Prenatal Substance Exposure
  • Understanding Your Rights: Quantum Corporation Securities Suit
  • PAL Aerospace Enhances Air Ambulance Services with New Aircraft
  • Neogen Corporation Class Action: Important Deadlines Approaching
  • Important Deadline for Replimune Group, Inc. Investors
  • Global Trustnet Enhances Cybersecurity and Blockchain Trust
  • Important Deadlines for KinderCare Investors: Act Now
  • Telix Pharmaceuticals Initiates Groundbreaking Prostate Trial
  • Strategic Offering: Capital Southwest's $350 Million Bond Deal
  • Secure Your Rights: Lockheed Martin Investor Actions Explained
  • Dania Beach Casino Enhances Engagement with Innovative QCI Tech
  • Key Steps for Alto Neuroscience Investors Before Deadline
  • NexPoint Real Estate Finance Declares Series A Preferred Dividend
  • Synopsys' Financial Insights: Q3 FY2025 Performance Review
  • Flagship REIT Enhances Growth Opportunities with Funding Expansion
  • Trackonomy's Strategic Acquisition of InPlay: A New Era in Smart Label Tech
  • DRE, A.P.C. Defends Bishop Montgomery Football Program Integrity
  • CenterWell Advances with Acquisition of The Villages Health Assets
  • Michigan House Hearing Spotlights Drone Infrastructure Needs
  • Raymond James Secures $1.5 Billion in Senior Notes Offering
  • How a $100 Investment in Morgan Stanley Has Grown Over Time
  • Kindly MD Soars on QMMM’s Crypto Treasury Movements
  • LifeMD Faces Lawsuit Over Financial Transparency Issues
  • Celebrating the Importance of School Partnerships This Year
  • C3.ai Faces Class Action Over Alleged Misleading Financial Claims
  • Capital Southwest Corporation Unveils $350M Note Offering for 2030
  • Celebrating Innovation in Chemical Engineering: 2025 Awards
  • Innovative AI Partnership to Transform Pilot Training Experience
  • Fossil Group, Inc. Launches Comprehensive Financing Initiatives
  • PrimeEnergy Resources Corp Achieves Prestigious National Recognition
  • Investigation Update on SoundHound AI, Inc. Shareholder Claims
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site